MedTrace Logo

Long-term Intervention Effects of a Personalized, Home-based Exercise Program and Nutritional Advice, Along With the Inclusion of a Pre-workout Multi-ingredient Supplement on the Body Composition, Functional Capacity and Quality of Life of Middle-aged and Older Adults (40-70 Years)

NCT04630977 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3000

Last updated 2021-12-15

No results posted yet for this study

Summary

The purpose of this study is to analyse the potential benefits of ingesting a commercially available pre-workout multi-ingredient supplement providing \~90 Kcal. for 25g of powder: carbohydrates -isomaltulose, fructose, maltodextrin- 15 g, essential amino-acids -Beta-alanine -L-arginine AKG, L-Leucine, Taurine, L-citrulline- 6.8 g, Creatine monohydrate: 2g, Guarana Extract: 800mg, total caffeine: 160mg, and Magnesium: 112.5mg) vs Placebo CHO intake on body composition, physical performance, Happiness Score (specially designed by our sponsor company, including different self-reported and validated tests on their short form) and every workout: Self-perceived energy feeling and adherence to the intervention.

Conditions

  • Muscle Loss
  • Obesity
  • Obesity, Abdominal
  • Weight Loss
  • Happiness
  • Quality of Life
  • Self-Perception
  • Stress, Psychological

Interventions

DIETARY_SUPPLEMENT

Multi-ingredient Pre-workout supplement

Every important issue has been detailed before.

OTHER

Progressive Resistance Training

The information about it has been detailed in advance.

BEHAVIORAL

Nutritional Patterns Guideline

This intervention has also been described in advance.

Sponsors & Collaborators

  • Ingesport Health Spa Consulting

    collaborator UNKNOWN

  • University of Greenwich

    lead OTHER

Principal Investigators

  • Fernando J Naclerio, Dr · University of Greenwich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-05-01
Completion
2023-05-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04630977 on ClinicalTrials.gov